A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
Clinical trial NCT07219420 · RECRUITING
Trial details
- NCT number
- NCT07219420
- Sponsor
- UCB Biopharma SRL
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-14
- Primary completion
- 2027-12-27
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.